Regeneron Pharmaceuticals
(REGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 271,466 | 199,097 | 247,796 | 314,684 | 292,129 |
| Marketable Securities | 120,452 | 216,785 | 226,954 | 348,924 | 408,275 |
| Receivables | 60,046 | 48,209 | 35,212 | 42,206 | 32,838 |
| TOTAL | $465,032 | $483,791 | $521,442 | $715,540 | $742,393 |
| Non-Current Assets | |||||
| PPE Net | 195,408 | 109,840 | 142,035 | 72,825 | 64,231 |
| Investments And Advances | 72,845 | 78,460 | 51,061 | 27,603 | 44,089 |
| Other Non-Current Assets | 9,060 | 9,330 | 9,682 | 9,923 | 512 |
| TOTAL | $277,313 | $197,630 | $202,778 | $110,351 | $108,832 |
| Total Assets | $742,345 | $681,421 | $724,220 | $825,891 | $851,225 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 51,881 | 44,832 | 36,168 | 41,887 | 38,289 |
| TOTAL | $120,424 | $103,113 | $83,672 | $217,771 | $223,918 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 68,543 | 58,281 | 47,504 | 58,381 | 66,976 |
| Other Non-Current Liabilities | 1,235 | 13,150 | 2,431 | 2,885 | 0 |
| TOTAL | $211,415 | $167,988 | $219,034 | $171,187 | $176,310 |
| Total Liabilities | $331,839 | $271,101 | $302,706 | $388,958 | $400,228 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,179 | 80,092 | 79,977 | 79,648 | 79,263 |
| Common Shares | 80 | 80 | 80 | 79 | 79 |
| Retained earnings | -903,591 | -893,408 | -873,265 | -844,409 | -823,294 |
| Other shareholders' equity | 1,014 | -1,248 | -114 | -3,960 | -315 |
| TOTAL | $410,506 | $410,320 | $421,514 | $436,933 | $450,997 |
| Total Liabilities And Equity | $742,345 | $681,421 | $724,220 | $825,891 | $851,225 |